Research Purposes Only: The compounds discussed on this site (BPC-157, TB-500) are explicitly for laboratory research use only. They are not FDA-approved for human consumption, medical treatment, or dietary supplementation. The information provided is for educational and harm-reduction purposes and does not constitute medical advice.

Trust & Transparency

Medical Review Policy

Last Updated: March 2026

The field of regenerative peptides evolves rapidly, and maintaining clinical accuracy is paramount. Wolverine Stack employs a strict Medical Review Process to assure that our core content aligns with the scientific consensus and adheres to harm-reduction principles.

The Review Process

Crucial pages detailing peptide mechanisms, clinical studies, safety profiles, and dosage frameworks undergo formal medical review. This process entails:

  1. Initial Research: Our medical writing team aggregates data strictly from published clinical literature (PubMed, NIH, etc.).
  2. Drafting: Content is drafted without hyperbole, strictly noting the differences between human, animal, and *in vitro* data.
  3. Clinical Audit: A board-certified physician (such as our lead reviewer, Dr. Igor Bussel) audits the draft to verify physiological accuracy, check the context of cited studies, and ensure potential risks are appropriately highlighted.
  4. Revision & Publication: The content is adjusted to resolve any clinical inaccuracies and then published with a "Last Reviewed" stamp indicating the date of the audit.

Our Primary Medical Reviewer

IB

Dr. Igor Bussel, MD, MS, MHA

Dr. Bussel serves as the lead medical auditor for Wolverine Stack. He is a physician-scientist with a background in clinical research and healthcare administration. His role is strictly to audit content for scientific accuracy and harm reduction; his review does not constitute an endorsement of unapproved peptide usage.

Limitations of the Review

Our content is medically reviewed for accuracy against existing literature, but it is not medical advice. BPC-157 and TB-500 are not FDA approved. Our reviewers do not recommend the acquisition or use of these compounds. The review process is designed exclusively to ensure researchers and readers have access to factually sound information.